Figures & data
Table 1. Baseline patient data.
Table 2. Surgical data of electrode and generator placement.
Figure 1. Comparison of LED in both groups showing a significant decrease of dosage in all postoperative time intervals (p ≤ 0.01**).
![Figure 1. Comparison of LED in both groups showing a significant decrease of dosage in all postoperative time intervals (p ≤ 0.01**).](/cms/asset/3ffe144a-b0cf-4bf2-9f6c-76d0a7d7ea72/icsu_a_1076042_f0001_c.jpg)
Figure 2. Pre- and postoperative UPDRS in both groups, depending on time course (preoperative, 3, 6 and 12 months after STN-DBS; p ≤ 0.01**; p ≤ 0.05*). Improvement of motor functionality is comparable in conventional stereotactic group (group I) and Starfix® miniframe group (group II).
![Figure 2. Pre- and postoperative UPDRS in both groups, depending on time course (preoperative, 3, 6 and 12 months after STN-DBS; p ≤ 0.01**; p ≤ 0.05*). Improvement of motor functionality is comparable in conventional stereotactic group (group I) and Starfix® miniframe group (group II).](/cms/asset/327f412f-99bf-4cad-adff-c6e174fd862d/icsu_a_1076042_f0002_c.jpg)
Figure 3. Reduction in L-Dopa dose in both groups is significant (p ≤ 0.01**) in the postoperative course 3, 6 and 12 months after DBS compared to initial preoperative L-Dopa dose. postop, postoperatively.
![Figure 3. Reduction in L-Dopa dose in both groups is significant (p ≤ 0.01**) in the postoperative course 3, 6 and 12 months after DBS compared to initial preoperative L-Dopa dose. postop, postoperatively.](/cms/asset/6a9743c8-9082-43df-a0cb-03c0a522d83e/icsu_a_1076042_f0003_c.jpg)